Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Fred Poordad

51-75 of 75 results

De Novo Non-Alcoholic Fatty Liver Disease Following Orthotopic Liver Transplantation

scientific article published on November 1, 2003

Overall safety profile of boceprevir plus peginterferon alfa-2b and ribavirin in patients with chronic hepatitis C genotype 1: a combined analysis of 3 phase 2/3 clinical trials

scientific article published on 9 October 2013

Morbidity in live liver donors: standards-based adverse event reporting further refined

scientific article

Ledipasvir/sofosbuvir-based treatment of patients with chronic genotype-1 HCV infection and cirrhosis: results from two Phase II studies

scientific article

Pegylated-interferon plus ribavirin therapy in the treatment of CHC: individualization of treatment duration according to on-treatment virologic response

scientific article

High antiviral activity of NS5A inhibitor ABT‐530 with paritaprevir/ritonavir and ribavirin against hepatitis C virus genotype 3 infection

scientific article published on February 3, 2016

Big Changes Are Coming in Hepatitis C

scientific article published on February 1, 2011

Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders

scientific article published in December 2009

Interferon Free Hepatitis C Treatment Regimens: The Beginning of Another Era

scientific article published on February 1, 2012

Absence of effect of telbivudine on cardiac repolarization: results of a thorough QT/QTc study in healthy participants

scientific article published on 15 October 2009

Efficacy of interferon alpha-2b induction therapy before retreatment for chronic hepatitis C.

scientific article published in October 2007

Viral resistance in hepatitis B: prevalence and management

scientific article

Infections During Peginterferon/Ribavirin Therapy Are Associated With the Magnitude of Decline in Absolute Lymphocyte Count: Results of the IDEAL Study

scientific article published on 06 January 2014

Management of Overt Hepatic Encephalopathy

scientific article published on February 1, 2012

Safety of the 2D/3D direct-acting antiviral regimen in HCV-induced Child-Pugh A cirrhosis - A pooled analysis

scientific article

Preclinical Profile and Clinical Efficacy of a Novel Hepatitis C Virus NS5A Inhibitor, EDP-239.

scientific article published on 08 August 2016

Review: Rapid virological response to peginterferon alfa and ribavirin treatment of chronic hepatitis C predicts sustained virological response and relapse in genotype 1 patients

scientific article published on March 1, 2009

Percutaneous liver biopsy after living donor liver transplantation resulting in fulminant hepatic failure: the first reported case of hepatic compartment syndrome

scientific article

An HCV-positive recipient of an HCV-positive donor liver successfully treated before and immediately after liver transplant with daclatasvir, sofosbuvir, and ribavirin

scientific article published on 3 February 2017

Diagnosis, Treatment, and Monitoring of Patients With Primary Biliary Cholangitis

scientific article published on September 2016

Evaluating medical resource utilization and costs associated with thrombocytopenia in chronic liver disease patients

scientific article published on November 4, 2011

Boceprevir plus peginterferon α-2b/ribavirin in chronic hepatitis C genotype 1: impact of baseline viral load on sustained virologic response

scientific article published on May 2014

The impact of an educational program on HCV patient outcomes using boceprevir in community practices (OPTIMAL trial)

scientific article published on September 1, 2015

Response to Cytoplasmic rods and rings in ribavirin and Cytoplasmic rods and rings in mycophenolic acid treatment

scientific article

Treatment of Hepatitis C Virus Genotype 3 Infection

scientific article published on October 2015